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ABSTRACT Positive-stranded viruses synthesize their RNA inmembrane-bound organelles, but it is not clear how this benefits
the virus or the host. For coronaviruses, these organelles take the form of double-membrane vesicles (DMVs) interconnected by
a convoluted membrane network. We used electronmicroscopy to identify murine coronaviruses with mutations in nsp3 and
nsp14 that replicated normally while producing only half the normal amount of DMVs under low-temperature growth condi-
tions. Viruses with mutations in nsp5 and nsp16 produced small DMVs but also replicated normally. Quantitative reverse tran-
scriptase PCR (RT-PCR) confirmed that the most strongly affected of these, the nsp3 mutant, producedmore viral RNA than
wild-type virus. Competitive growth assays were carried out in both continuous and primary cells to better understand the con-
tribution of DMVs to viral fitness. Surprisingly, several viruses that produced fewer or smaller DMVs showed a higher fitness
than wild-type virus at the reduced temperature, suggesting that larger andmore numerous DMVs do not necessarily confer a
competitive advantage in primary or continuous cell culture. For the first time, this directly demonstrates that replication and
organelle formationmay be, at least in part, studied separately during infection with positive-stranded RNA virus.
IMPORTANCE The viruses that cause severe acute respiratory syndrome (SARS), poliomyelitis, and hepatitis C all replicate in
double-membrane vesicles (DMVs). The big question about DMVs is why they exist in the first place. In this study, we looked at
thousands of infected cells and identified two coronavirus mutants that made half as many organelles as normal and two others
that made typical numbers but smaller organelles. Despite differences in DMV size and number, all four mutants replicated as
efficiently as wild-type virus. To better understand the relative importance of replicative organelles, we carried out competitive
fitness experiments. None of these viruses was found to be significantly less fit than wild-type, and two were actually fitter in tests
in two kinds of cells. This suggests that viruses have evolved to have tremendous plasticity in the ability to formmembrane-
associated replication complexes and that large and numerous DMVs are not exclusively associated with efficient coronavirus
replication.
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Positive-stranded RNA viruses form intracellular membrane-bound organelles after infection, and these organelles are be-
lieved to facilitate intracellular RNA replication (1, 2). In the coro-
naviruses, which cause diseases in humans, including severe acute
respiratory syndrome (SARS) and Middle Eastern respiratory syn-
drome (MERS), these replicative structures take the form of
double-membrane vesicles (DMV), which later develop into clus-
ters where the outer DMV membranes are connected by a network
of convoluted membrane (CM) tubules (3–5). DMV clusters are
derived from the endoplasmic reticulum (ER) or ER-Golgi inter-
mediate compartment (4, 6) and contain newly synthesized viral
RNA and viral replicase proteins (4, 7–13). Previous reports have
linked organelle formation to ongoing RNA replication (4, 14,
15). This has been interpreted as evidence that DMVs either are
required for coronavirus RNA synthesis or are generated as a re-
sult of viral RNA synthesis (4, 14).
The SARS coronavirus (SARS-CoV) replicative machinery
consists of up to sixteen nonstructural proteins (nsp1 to nsp16),
which are processed from large polyproteins (reviewed in refer-
ence 16). The conserved gene cluster from the nsp3 gene to the
nsp6 gene contains all the factors necessary for DMV formation:
nsp3, nsp4, and nsp6 are needed to form DMV clusters (17) after
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essential processing by proteinases located in nsp3 (18) and nsp5
(19). Electron microscopy suggests that nsp3 induces membrane
proliferation (17). nsp3 and nsp4 localize predominantly to the
CM in DMV clusters (4, 9, 20) and are sufficient to induce struc-
tures resembling CMs in the absence of other viral proteins (17).
Mutations in nsp4 have been linked to formation of aberrant
DMVs with apparent defects in membrane pairing (21). nsp6
from several coronaviruses causes single-membrane LC3-
containing vesicles (22) to accumulate around microtubule orga-
nization centers (17), although it is not clear how this is connected
to the formation of DMV clusters.
Some replicase subunits work together in units known as cis-
trons. Five cistrons (0, I, II, IV, and VI) have been defined, with
gaps left in the naming scheme in case new cistrons are discovered
that map to nsp13 and nsp15, respectively (14, 23). Complemen-
tation studies using temperature-sensitive (ts) mutants of mouse
hepatitis virus (MHV) have showed that mutations in nsp3,
nsp12, nsp14, and nsp16 protein define distinct cistrons (cistrons
0, II, IV, and VI, respectively), while mutations in nsp5 and nsp10
proteins define a single cistron (cistron I) (14, 23–25).
Temperature-sensitive mutations in coronavirus nsp3, nsp5,
nsp10, nsp12, nsp14, and nsp16 have been reported, all of which
permit RNA synthesis at 33°C but cause RNA synthesis defects at
40°C (14, 24–28).
In this study, we examined the intracellular organelle pheno-
type of MHV strains with temperature-sensitive (ts) mutations in
each of the known cistrons. Both mutant and control viruses were
grown at 33°C, a temperature selected to allow full growth of mu-
tant viruses. We chose to work with ts viruses as a pool of ready-
made replicase point mutants that have been preselected for both
robust growth at 33°C and functional importance, since each of
the ts mutations is lethal at 40°C. We carried out these tests in
order both to better understand the connection between organ-
elles and viral RNA synthesis and to examine whether mutation of
critical residues produces a detectable effect on the replicative or-
ganelle. To do this, we quantified virus release, DMV formation,
RNA synthesis, and competitive fitness in a variety of cell types.
RESULTS
Genetics and growth of mutant viruses. Wild-type MHV-inf-1
and five mutant MHV strains selected on the basis of defective
RNA synthesis at 40°C were used in this study (Fig. 1). Brts31
contains a mutation in a region that likely forms an interdomain
flexible linker in nsp3 (29, 30), which paradoxically interferes with
the function of the nsp5 main proteinase (Mpro) at 40°C (14).
Albts16 has a mutation in a loop within the carboxyl-terminal
domain of Mpro (23, 31). Albts22 has a mutation in the predicted
thumb domain of the polymerase fold near the carboxyl terminus
of nsp12 (23, 32). Wüts18 has a mutation on the surface of the viral
2=-O-methyltransferase (23, 33). The last mutant chosen was the
previously undescribed Brts105, which contains a single proline to
serine substitution (CCA to UCA) at position 19320 in sequence
AY700211 (Fig. 1). The Brts105 mutation falls in the viral N7-
methyltransferase domain of nsp14 (34), between the previously
characterized Wüts38 and Albts17 mutations, both of which map
to cistron IV (23).
Brts105 was subjected to several tests to characterize its growth
at 33°C and 40°C. The replication of Brts105 was compared to that
of both the wild type and the better-characterized Brts31 mutant
in primary mouse embryo fibroblast cells (Fig. 2A). Brts105
growth was slightly delayed compared to that of the wild type and
Brts31 but reached a similar peak titer. Neither Brts105 nor Brts31
virus grew at 40°C (Fig. 2B), and Brts105 did not produce RNA at
40°C (Fig. 2C), demonstrating that growth of both viruses was
temperature sensitive.
Functional characterization of ts viruses. To better under-
stand the functional consequences of activating the ts phenotype
of Brts105, we performed a stop/resume assay, which was designed
as a simple tool to compare the severity of ts phenotypes. The assay
takes advantage of the eclipse phase, during which RNA replica-
tion takes place but no new virus emerges, which lasts for 6 h after
inoculation (5). The stop/resume assay works by stopping RNA
synthesis 4.5 h after inoculation, during the eclipse phase. After 3 h
under stopped conditions, RNA synthesis was then either re-
sumed for 4 h, in order to allow the release of new virus with the
participation of previously synthesized components, or kept un-
der stopped conditions (Fig. 2D). If the resumed titer was signif-
icantly higher than the stopped titer (typically about a 10-fold
increase), then the ts phenotype was classified as mild, meaning
that some residual function or functional components were avail-
able after the stoppage period, but if the titer did not increase
significantly after resumption, then the ts phenotype was classified
as severe.
The results of a stop/resume assay for Brts105 are shown in
Fig. 2E and were typical of the mild phenotype. Stop/resume as-
says were performed at least twice, with three replicates per time
point. Results for other viruses are summarized in Fig. 2F. Brts105,
Brts31, and Albts16 displayed mild ts phenotypes. This was con-
sistent with the previously described mild ts phenotype of Albts16
(23). The ts phenotype of Albts22 was found to be severe, as pre-
FIG 1 Genetic characteristics of MHV mutants. The schematic shows amino acid changes responsible for temperature-sensitive phenotypes of viruses used in
this study. Amino acid positions are numbered from the start of each nonstructural protein. Functions of potentially affected domains that are marked include
papain-like proteinases (PL1pro and PL2pro), ADP-ribose 1 phosphatase (ADRP), main proteinase (Mpro), RNA-dependent RNA polymerase (RdRp), and
methyltransferases (N7-MT and 2O-MT).
Al-Mulla et al.
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viously reported (23), and was equivalent in severity to treatment
with cycloheximide, which blocks translation and has been shown
to result in inactivation of replicase components in about 1 h (23,
35, 36).
We next compared the growth of the panel of viruses at 33°C
on continuous 17Clone-1 fibroblasts (17Cl-1), primary mouse
embryo fibroblasts (MEFs), adipose-derived mesenchymal stem
cells (ADMSC), and bone marrow-derived stem cells (BMSC)
(Table 1). All of the mutants except Albts22 grew to approximately
wild-type levels at 33°C in every cell type tested. Albts16 grew
slightly slower than the wild type in 17Cl-1 cells but grew to wild-
type levels in MEFs. Albts22 consistently produced about one-
FIG 2 Characterization of Brts105 growth. Viruses were inoculated at a multiplicity of 10 PFU/cell on primary MEFs (mouse embryo fibroblasts) at 33°C for
1 h and then incubated at either 33°C (A) or 40°C (B) for the duration of the experiment. Viral growth was measured by plaque assay at 33°C. The average of three
replicates is shown. Dotted lines indicate the lower limit of detection for the plaque assay. (C) Northern blots show the effect of temperature on viral RNA
production by the wild type and Brts105. Bands corresponding to viral subgenomic RNAs 4 to 7 are indicated. (D to F) The relative severity of ts phenotypes was
characterized by a growth stop/resume assay. Growth was stopped 4.5 h after inoculation by incubating ts virus at 40°C or by treating wild-type virus with
10g/ml cycloheximide (CHX). After 3 h of arrested growth, the inhibition was either maintained to the end of the experiment (Stopped) or released (Resumed).
Virus growth was measured by plaque assay, and the results for Brts105 are shown in panel E. The averages for 6 replicates are shown. The titer ratio (resumed
to stopped) from panel E is shown in comparison to other mutants and CHX treatment in panel F. Statistically significant increases in titer after resumption are
indicated (*, P 0.05; ns, not significant).
TABLE 1 Comparative growth characteristics of MHV mutantsa
Cell line
Conditions
Titer (log) of
wild typeb
Titer difference relative to wild type (log)
Time (h) Temp (°C) Brts31 Albts16 Brts105 Wüts18 Albts22
17Cl-1 14 33 6.9 0.3 0 0.6 0.2 0.4 0.8
MEF 24 33 5.3 0.4 0.1 0.4 0.3 0.1 1
MEF 48 33 7.1 0.2 0.2 NDc 0 ND ND
MEF 72 33 4.6 0.4 ND 0 ND ND ND
ADMSC 48 33 6.2 0.1 0.1 ND ND ND ND
BMSC 18 33 3.8 0.2 0 ND ND ND ND
17Cl-1 14 40 5.1 0.2 3.8 3.4 3.8 2.7 3.8
MEF 24 40 5.6 0.2 4.3 4.3 4.3 4.3 3.5
a Effects of mutations on viral growth were assessed at permissive (33°C) and nonpermissive (40°C) temperatures in continuous (17Cl-1) and primary (MEF, ADMSC, and BMSC)
cell cultures. Titer differences were calculated from a minimum of three replicates.
b The wild-type titer is shown as the mean standard deviation.
c ND, not determined.
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tenth as many infectious progeny as wild-type virus. These results
showed that, except for Albts22, the panel of mutants displayed
growth characteristics similar to those of wild-type virus at 33°C.
These results were consistent with previous results, which showed
that Wüts18 (37) and Brts31 (14) grow to wild-type levels at 33°C,
while growth of Albts22 is attenuated even at 30°C (23).
Aberrant DMV formation at 33°C. Cells were infected at high
multiplicity with wild-type or mutant viruses and then examined
by electron microscopy to investigate the effects of mutations on
replicative organelle formation at 33°C. One randomly oriented
ultrathin section per cell was examined in order to compare the
sizes and numbers of intracellular organelles virions, as described
previously (17).
Clusters of DMVs were observed next to regions of CM in
17Cl-1 cells infected with wild-type and mutant viruses (Fig. 3A).
However, all of the mutants produced smaller DMVs than wild-
type virus, varying from nearly wild-type size (Brts105) to approx-
imately 10% smaller (Brts31, Wüts18, and Albts22) to 17% smaller
(Albts16). Many DMV-containing cells also contained intracellu-
lar virus particles (Fig. 3B), which did not differ significantly in
size from wild-type controls.
DMV size was measured in order to better understand the ef-
fects of the mutations on DMV synthesis. Altogether, 4,646 DMVs
were measured at various times after infection in three continuous
cell lines. Under every condition that was tested, mutant viruses
formed significantly smaller DMVs than wild-type viruses (Ta-
ble 2). The only revertant virus tested produced DMVs of wild-
type size (Wüts18 revertant in L929 cells in Table 2). To control for
the possibility that DMV size differences were due to variation in
preparation for electron microscopy, 1,352 intracellular virions
were measured from the same micrographs. No significant differ-
ences in intracellular virion size were observed (Table 2). To-
gether, this demonstrated that Brts31, Albts16, Albts22, Brts105,
and Wüts18 have small DMV phenotypes at 33°C.
Fewer DMVs formed at 33°C. Ultrathin sections of infected
17Cl-1 and DBT cells were next examined for the prevalence of
visible signs of infection in order to determine whether any of the
mutations affected the number of DMV clusters present. For the
combined viruses, 2,285 ultrathin cell sections were examined for
the presence of intracellular signs of infection. Sections containing
intracellular virions or DMV clusters were counted and photo-
graphed, and the number of each was recorded. Cells inoculated
with Brts31 and Brts105 each contained about half the expected
number of DMV-positive cells at 33°C compared to the wild type,
despite a similar prevalence of cells with intracellular virions visi-
ble (Table 3). The prevalence of DMV and virion-containing cells
did not differ from that in the wild-type controls for Albts16 and
Wüts18, but Albts22 produced significantly fewer signs of infec-
tion (Table 3). These results demonstrated that Albts22, Brts31,
and Brts105 produced fewer DMV clusters than wild-type virus.
The number of DMVs per cell was measured in order to better
quantify differences in organelle prevalence. Brts31 DMV clusters
contained about a three-quarters as many DMVs as wild-type
clusters both early and late in infection (Table 3). Albts22 clusters
contained about two-thirds as many DMVs as wild-type clusters,
consistent with the severely attenuated growth. For all viruses ex-
amined, there was one CM present per approximately 7 DMVs
and 1 to 5 DMV clusters per cell section, when present (data not
shown). Collectively these data distinguish two low-DMV pheno-
types that occurred without attenuation of the virus: Brts105
formed fewer DMVs of near-normal size, while Brts31 formed
fewer DMVs of smaller-than-normal size.
DMV capacity and RNA synthesis. Viral RNA accumulates in
DMVs, leading to the interpretation that DMV clusters are the
FIG 3 Replicative organelles formed at 33°C by MHV mutants in 17Cl-1 cells. (A) Positions of double-membrane vesicles (stars), intracellular virus (arrow-
head), and convoluted membrane (c) in infected cells are marked. (B) Magnified images of intracellular virus particles from each virus.
Al-Mulla et al.
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primary site of RNA replication (4), although a recent study has
called into question whether all DMVs are active in RNA synthesis
(38). In this case, the total DMV capacity in an infected cell may
limit the amount of viral RNA synthesis that can take place inside
a cell. To estimate total DMV capacity, DMV size (Table 2) was
multiplied by the relative percentage of DMV-containing cells
(Table 3) and multiplied by the number of DMVs per cluster
(Table 3) to estimate the relative DMV capacity of cells infected
with wild-type and mutant viruses. Results were normalized to
those for wild-type controls grown at 33°C and are shown in Ta-
ble 3.
It has been previously shown that wild-type MHV produces
about twice as much viral RNA at 40°C as at 33°C (23) (Fig. 2C).
To test whether this increased RNA synthesis was reflected in the
number or size of replicative organelles, cells infected with wild-
type virus and incubated at 40°C and 33°C were examined. Organ-
elles formed at 40°C were smaller (Table 2) but more numerous
(31 per cell compared to 18 per cell at 33°C), effectively doubling
DMV capacity (Fig. 4A). These results demonstrated that condi-
tions reported to increase RNA yield correlated with increased
DMV capacity for wild-type MHV.
Albts22 displayed the lowest relative DMV capacity among the
viruses we examined (Fig. 4A). The nearly tenfold reduction in
Albts22 DMV capacity compared to wild-type corresponded well
with nearly tenfold-lower production of infectious progeny (Ta-
ble 1). However, DMV capacity correlated poorly with yield for
Brts31, which produced infectious progeny at wild-type levels de-
spite having only 35% of the DMV capacity of wild-type virus
(Table 3). This suggested two possibilities: that Brts31 packages a
reduced amount of RNA more efficiently than wild-type virus, or
that Brts31 synthesizes normal amounts of RNA from a smaller-
than-normal number of organelles.
To discriminate between these possibilities, wild-type and
Brts31 RNA synthesis was compared by quantitative RT-PCR.
Genomic and subgenomic RNA 7 synthesis was quantified using
primers specific to the nsp3-encoding region and across the
leader-body junction of subgenomic RNA 7, respectively. Brts31
synthesized somewhat larger amounts of genomic and sub-
TABLE 2 DMV and virion size in infected cells
Conditions Virus ts
Double-membrane vesicles Intracellular virions
n Sizea (nm) Pb n Sizea (nm) P
L929, 37°C, 5 hpic Wild-type 302 179 36 63 75 9
Wüts18 nsp16 196 157 61 2 106 77 75 8 NSd
Revertant nsp16e 165 178 31 NS 42 77 13 NS
DBT, 33°C, 5.5 hpi Wild type 468 228 45 74 69 8
Brts31 nsp3 58 195 38 2 106 70 69 9 NS
DBT, 40°C, 5.5 hpif Wild type 841 218 50 9 105 141 71 10 NS
17cl1, 33°C,10 hpi Wild type 604 228 36 169 68 10
Brts31 nsp3 403 208 34 5 1019 263 68 10 NS
Albts16 nsp5 459 189 33 8 1066 102 70 8 NS
Brts105 nsp14 463 220 36 2 104 278 69 10 NS
Wüts18 nsp16 456 211 35 2 1015 39 67 12 NS
Albts22g nsp12 231 204 43 2 1013 34 68 11 NS
a Size was calculated as perimeter length divided by ; data are means standard deviations.
b Compared to the wild-type (Wüts18) or revertant (Brts31) control by Mann-Whitney test.
c Wüts18 and the revertant grow to wild-type levels at 37°C (41).
d NS, not significantly different from the corresponding wild-type control.
e Containing the original ts mutation in nsp16 plus a compensating mutation in nsp16 N43S.
f Incubated at 33°C for 3.5 h and then shifted to 40°C.
g Attenuated growth at 33°C compared to the wild type.
TABLE 3 DMV and intracellular virion (IV) prevalence in infected cells
Conditions Virus ts
No. of
cells
Prevalence of intracellular signs
of infection No. per cell section when present
Rel. DMV
capacity (%)bDMV (%) Pa IV (%) P DMV P IV P
DBT, 33°C, 5.5 hpi Wild type 323 6 7  18 20 3 4  100 60
Brts31 nsp3 753 2 8 104 7 NSc 6 6 1 102 3 4 NS 20 12
17Cl-1, 33°C, 10 hpi Wild type 161 40 29 9 9 4 3 100 48
Brts31 nsp3 238 24 4 104 25 NS 7 8 4 104 4 6 NS 35 18
Albts16 nsp5 120 37 NS 19 NS 9 8 NS 4 4 NS 53 28
Brts105 nsp14 230 22 1 104 32 NS 9 13 NS 4 4 NS 49 25
Wüts18 nsp16 140 36 NS 20 NS 9 10 NS 2 1 7 103 71 36
Albts22d nsp12 320 13 1 105 9 1 105 6 5 NS 1 0.4 1 105 16 10
a Calculated by Fisher’s exact test.
b Relative DMV capacity was calculated as follows: average DMV size ( standard deviation) percentage of cell sections with DMVs DMVs per section, relative to wild-type.
c Not significantly different from the corresponding wild-type control.
d Attenuated growth at 33°C compared to the wild type.
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genomic RNA than the wild type at 33°C, as shown in Fig. 4B.
Together, these data demonstrate that efficient RNA production is
not necessarily correlated with large or numerous DMVs.
DMVs and fitness. To better understand the role of DMV for-
mation in the virus replication cycle, we carried out competitive
fitness assays on all the viruses that grew to approximately wild-
type titers. In these assays, an equal number of plaque-forming
units of wild-type virus and one ts virus were added at low multi-
plicity to either continuous or primary cells, which were then in-
cubated at 33°C. Fitness was calculated as the ratio of mutant virus
to wild-type virus present in the supernatant at the end of the
competition. In this assay, a ratio of 1 would indicate that the
viruses were equally fit, higher ratios indicate that the mutant
virus is fitter than the wild type, and lower ratios indicate that the
mutant virus is less fit than the wild type. Viruses were differenti-
ated by means of plaque assays initiated at 33°C for 1 h and then
continued by incubation at either 40°C (where only the wild type
forms plaques) or 33°C (where both viruses form plaques). The
assay was validated by performing differential plaque assays on
pure samples of the wild type and Brts105 (Fig. 5A). The number
of plaques formed by the wild type did not differ significantly at
the two temperatures. Brts105 formed plaques in 33°C plaque as-
says but not in plaque assays initiated at 33°C and then continued
by incubation at 40°C (Fig. 5A). This demonstrated that titers of
FIG 4 RNA synthesis and relative DMV capacity. (A) Relative DMV capacity was estimated as DMV size ( standard deviation) percentage of cell sections
with visible DMVs average number of DMVs per cell and expressed as a percentage of wild-type DMV capacity (indicated by the dotted line). (B) Viral genomic
and subgenomic RNA synthesis at 10 h postinoculation in 17Cl-1 cells was measured by quantitative RT-PCR and is expressed as an amount relative to wild-type
RNA synthesis. Statistically significant differences in RNA load are indicated (***, P 0.001; ns, not significant).
FIG 5 Viral fitness assay validation and results. (A) Numbers of plaques generated by samples of the wild type and Brts105. Plaque assays were inoculated at 33°C
for 1 h and then incubated at 33°C and 40°C. Results were normalized to the average titer obtained from the 33°C plaque assays and are averages for 14 replicates
for the wild type or 8 replicates for Brts105. A titer below the 25-PFU/ml lower limit of detection is indicated (). (B) Relative fitness of MHV mutants in
continuous 17Cl-1 and primary MEFs, as determined by plaque assays at both 33°C and 40°C for each sample. Fitness is expressed as (33°C titer  40°C
titer)/40°C titer. Error bars show standard deviation. Statistically significant differences between the titer of ts virus (33°C titer 40°C titer) and wild-type virus
(40°C titer) are indicated (*, P 0.05; ns, not significant; nt, conditions not tested). (C) DNA sequencing results for the wild type, Brts105, and a 1:1 mixture of
wild-type and Brts105 viruses. (D) Results of competitive fitness assays performed in triplicate with 1:1, 3:1, and 5:1 ratios of Brts105 to wild-type virus as
determined by RT-PCR and DNA sequencing. Results are ratios of the two viruses based on peak height from direct cDNA sequencing and are from three
replicate sequences.
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wild-type and ts viruses can be distinguished by differential plaque
assays and that the reversion rate of Brts105 was less than 105 and
therefore would not detectably complicate the interpretation of
competition experiments, which typically produced more than
106 PFU/ml.
Brts105 and Wüts18 showed a small but statistically significant
increase in fitness compared to the wild type, Brts31 and Albts16
did not differ significantly in fitness from the wild type, and
Albts22 appeared somewhat but not significantly less fit than the
wild type in continuous cells (Fig. 5B). Results from primary
MEFs agreed with continuous-cell results. This also showed that
Brts105 and Wüts18 are cold adapted compared to wild-type vi-
rus, in addition to being ts. This demonstrated that viruses that
produce larger replicative organelles (Fig. 5) (Albts16, Wüts18,
and Brts31 versus the wild type) or more numerous replicative
organelles (Fig. 5) (Brts31 and Brts105 versus the wild type) do not
have a competitive disadvantage per se under these assay condi-
tions.
In order to further test whether the differential plaque assay
results reflected the proportion of wild-type and ts RNA released
into the supernatant at the end of a competition assay in 17Cl-1
cells, RT-PCR and DNA sequencing (39) were performed for
competition assays containing Brts105 and wild-type virus (Fig.
5C and D). In this assay, three replicates gave a fitness of 0.8 0.1
for Brts105, which fell within the range of results recorded by
plaque assay (0.4 to 6.4). The parity between Brts105 and the wild
type was maintained even when the relative abundance of each
virus at the beginning of the competition was altered (Fig. 5D).
This confirmed that Brts105 was not significantly less fit than wild-
type virus under these test conditions.
DISCUSSION
The formation of replicative organelles is a conserved strategy
among positive-stranded viruses and has led to the assumption
that viral organelles play an important and highly conserved role
in intracellular RNA replication (1, 2). Previous studies had
shown that newly synthesized viral RNA can be detected as early as
1 h after inoculation (40), but the earliest time at which DMVs
have been detected is 2 h after inoculation (4, 5), and complete
organelles with CM and DMVs were first reported 3 h after inoc-
ulation with MHV (5) or 4 h after inoculation with SARS-CoV (4),
suggesting that the replicative organelle may be a lagging indicator
of viral RNA synthesis. However, other studies have shown that
replicative organelles disappear within about 2 h of treatments
that strongly inhibit viral RNA synthesis (14, 15). In this study, we
documented viruses with a range of organelle sizes and prevalence
that were sufficient to support wild-type levels of viral growth.
This included two viruses of the six tested (Brts31 and Brts105)
that replicated normally with half the normal complement of or-
ganelles or less. These results extend findings that attenuated nsp4
mutant viruses produce fewer organelles than normal (21). To-
gether, these results suggest that there is a considerable plasticity
in the replication complex, since a variety of sizes and numbers of
DMVs can support RNA synthesis.
The data presented here do not necessarily disprove that DMV
clusters are needed for intracellular coronavirus RNA synthesis
but demonstrate that the link may be looser than anticipated. This
finding was anticipated by a recent study that demonstrated that
subcellular compartments that contain double-stranded RNA
(dsRNA) (i.e., probable DMVs) were not necessarily sites of active
RNA replication (38). We unexpectedly found that viruses that
produced larger and more numerous DMVs did not have a con-
sistent fitness advantage in primary or continuous cells under test
conditions. However, it is quite possible that further testing in
primary macrophages or live animals would reveal a competitive
advantage for increased organelle numbers or increased DMV ca-
pacity. A previous analysis of coronavirus RNA replication had
shown that viral dsRNA colocalizes well with nonstructural pro-
teins early in infection but that the correlation becomes less clear
over time (38). Nevertheless, these results are the first direct evi-
dence to our knowledge that intracellular RNA synthesis can be at
least partially decoupled from formation of replicative organelles.
We also report here for the first time that viruses with mutations in
all 5 known cistrons of the MHV replicase form either slightly or
substantially smaller DMVs, suggesting that while DMVs are
formed primarily by nsp3, nsp4, and nsp6 mutants (17), muta-
tions in any part of the replicase locus can potentially restrict
DMV formation. This suggests that the size and potentially the
form of the replicative organelle may be dependent on factors
other than the amount of RNA synthesis, such as the efficiency of
polyprotein processing.
DMVs are complex, containing viral replicase subunits, RNA,
host membranes, and host proteins (4, 5, 7–13, 41, 42), so some
changes in DMV size and number may be related to the efficiency
of the many poorly understood processes that contribute to DMV
formation. The results presented here should be taken with two
caveats: that the effects of the mutations may be indirect, and that
comparisons of growth and competition could be performed only
at reduced temperature. Although all ts viruses except for Albts22
matched the output of the wild type at reduced temperature, re-
duced temperature may affect replication and the processes that
lead to DMV formation differently.
The effect of the Brts31 mutation in reducing DMV formation
may be explained by the essential role of nsp3 in organelle forma-
tion (17). However, we could not find a simple explanation for
finding that the Brts105 mutation in nsp14, located over
15,000 nucleotides (nt) downstream of the Brts31 mutation, in a
domain which had not previously been shown to be essential for
DMV synthesis, also reduced organelle formation. While it is pos-
sible that the N7 methyltransferase activity of nsp14 is involved in
an early step of DMV formation, a more likely explanation is that
the mutation alters long-range protein folding or protein process-
ing that occurs upstream of DMV formation, as observed previ-
ously for mutations in nsp10 and nsp3 (14, 27). However, further
work will be needed to study the effects of the Brts105 mutation on
the function of other essential replicase proteins such as nsp5 (14,
27) or protein complexes such as the nsp10-nsp14-nsp16 RNA
cap methylation complex (43). Notwithstanding, the results pre-
sented here constitute the first demonstration of a functional link-
age between nsp14 and the DMV scaffold proteins.
MATERIALS AND METHODS
Viruses and cells. Wild-type control virus MHV-A59 and Brts31 were
propagated from recombinant vaccinia virus-based infectious clones as
described previously (14). MHV-Brts105 was isolated following selection
with 150 g/ml of 5-fluorouracil at 33°C for 16 h using the procedure
described for Brts31 (14). MHV-Brts105, Albts16, Wüts18, and Albts22
mutants were plaque purified twice on 17Cl-1 cells and completely se-
quenced to confirm the presence of the appropriate ts mutation and the
absence of other changes. 17Cl-1, DBT, and L929 cells were grown in
Dulbecco’s modified Eagle medium (DMEM; Invitrogen) supplemented
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with 5% tryptose phosphate broth (TPB; Sigma), 10% heat-inactivated
fetal bovine serum (FBS; Biosera), antibiotics, and nonessential amino
acids (NEAA; Invitrogen). Primary mouse embryo fibroblasts (Lonza),
adipose-derived mesenchymal stem cells (Cyagen), and bone marrow-
derived mesenchymal stem cells (obtained from Darwin Prockop at the
Health Science Center of Texas A&M University, Bryan, TX) were cul-
tured in DMEM supplemented with 10% FBS, NEAA, and antibiotics.
Virus titers were determined by plaque assay on 17Cl-1 cells.
Northern blotting. RNA for Northern blotting was obtained by in-
fecting ~107 17Cl-1 cells with virus at a multiplicity of 10 PFU per cell for
8 h at 33°C or 6 h at 39.5°C and isolating total RNA using the Trizol
reagent (Invitrogen, Paisley, United Kingdom) as described by the man-
ufacturer. The poly(A)-containing RNA was isolated using oligo(dT)25
Dynabeads (Dynal, Oslo, Norway) as previously described (44). The RNA
was then incubated with formamide (50%) and formaldehyde (2.2 M) at
70°C for 10 min and electrophoresed in a 1% agarose gel containing
20 mM MOPS (3-N-morpholinopropanesulfonic acid) and 600 mM
formaldehyde. After electrophoresis, the gel was soaked in 0.05 N NaOH,
neutralized, and equilibrated with 20 SSC (3 M NaCl, 0.3 M sodium
citrate, 1 mM EDTA) before being vacuum blotted onto a nylon mem-
brane (Optitran BA-S 83; Schleicher and Schuell, Sigma-Aldrich, Poole,
United Kingdom). The RNA was cross-linked to the membrane using UV
light, and MHV RNAs were detected by hybridization with a 466-bp,
-32P-, random-prime-labeled PCR product corresponding to sequences
in the nucleocapsid protein open reading frame of the MHV-A59 genome
(45).
Quantitative reverse transcriptase PCR (qRT-PCR).Duplicate flasks
were prepared so that RNA extraction and DMV analysis could be per-
formed on samples from the same experiment. Total cellular RNA was
extracted from infected cells 10 h after inoculation using an RNeasy mini-
kit (Qiagen). The RNA integrity was analyzed with the 2100 Bioanalyzer
using the RNA 6000 Nano kit (Agilent). Both cDNA synthesis and PCR
were performed in a single tube from total RNA using the SensiMix SYBR
one-step kit (Bioline). Genomic RNA was quantified by amplifying a
124-bp region from the nsp3 gene with the forward primer 5= AATAAG
CAGGAGGCAAATGTTC 3= and the reverse primer 5= CCCACAACAC
AATGAAACAAATC 3=. A 110-nt amplicon spanning the leader-body
junction of sgRNA7 was amplified using forward primer 5= GTACCCTC
TCAACTCTAAAAC 3= and reverse primer 5= GCGGTTTACAGAGGAG
CTT 3=. Amplifications were carried out in triplicate, with a 250 nM
primer concentration in 25-l reaction volumes. Melt curve analysis was
performed to confirm PCR product specificity. Absolute quantitation was
performed by comparison to a standard curve of cloned amplicons.
Electron microscopy. Cells were inoculated with at least 20 PFU of
virus per cell and maintained at 33°C. Infected cells were fixed in electron
microscopy-grade 4% glutaraldehyde (Sigma) in 0.1 M cacodylate buffer,
scraped from the plate, and then postfixed in 0.1 M cacodylate-buffered
1% osmium tetroxide for 1 h. The cells were dehydrated in increasing
concentrations of acetone and then embedded in Agar 100 resin (Agar
Scientific). Ultrathin sections that produced a silver interference pattern
(50 to 60 nm in thickness) were taken from embedded samples and post-
stained with 0.5% uranyl acetate. Electron microscopy was performed at
80 kV on a Philips CM20 equipped with a 2K charge-coupled devide
(CCD) camera or a Hitachi H600 equipped with film. Film negatives were
scanned into digital files using a Microtek i800 scanner. Cell sections used
here each contained a single visible nucleus, with intact nuclear and
plasma membranes. Images of DMV- and virion-containing cells meeting
these criteria were captured for later analysis.
Measurement of intracellular features was done using the boxer mod-
ule of EMAN (46). The longest and shortest diameters of each DMV and
intracellular virus particle were measured twice each by two observers.
The standard deviation between repeated measurements was about 2 pix-
els on average, which equated to approximately 7 nm at the level of the
specimen. Since most of the DMVs and virions had an elliptical profile,
size was estimated by Ramanujan’s first approximation for the perimeter
of ellipse, and the result was divided by  to approximate diameter.
Competitive fitness assays.Continuous 17Cl-1 cells or primary MEFs
(mouse embryo fibroblasts) were inoculated with a mixed virus pool con-
taining 0.005 PFU per cell each of wild-type virus and one ts mutant. Cells
were incubated at 33°C for 24 h on 17Cl-1 or 48 h on MEFs to allow the
viruses to complete several rounds of replication. Relative amounts of
wild-type and mutant virus were quantified either by RT-PCR following
the method of Hall and Little (39) or by two replicate plaque assays, of
which both were inoculated at 33°C for 1 h and then one was incubated at
33°C and the other at 40°C for 3 days. For RT-PCR quantification, re-
leased virus was concentrated by precipitation with 10% polyethylene
glycol 8000 and purified by pelleting through a sucrose-TNE (10 mM Tris,
100 mM NaCl, 1 mM EDTA) cushion (25% [wt/vol] sucrose in 50 mM
Tris-HCl [pH 7.4], 100 mM NaCl, and 0.1 mM EDTA). RNA was ex-
tracted from purified virus using an RNeasy minikit (Qiagen). Purified
wild-type and Brts105 RNAs were mixed in molar ratios from 1:5 to 5:1 for
use as standards at this stage. Virion RNA and standards were converted to
cDNA by reverse transcription with random hexamer primers and ampli-
fied with primers bracketing the mutation in Brts105, forward primer
5= GCAATAGGTATGATGTGTG 3= and reverse primer 5= GCTGTGGT
TGCCGTATTGTAAG 3=. Amplicons were then sequenced commercially
(Source Bioscience) using the same MHV-specific primers. Results were
regressed to the proportion of sequencing peak height, normalized to
standards.
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